Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATP1A1 | P05023 | 11/20 | 0.72 |
| ▸ | ATP1B1 | P05026 | 11/20 | 0.72 |
| ▸ | ATP1A3 | P13637 | 11/20 | 0.72 |
| ▸ | ATP1B2 | P14415 | 11/20 | 0.72 |
| ▸ | ATP1A2 | P50993 | 11/20 | 0.72 |
| ▸ | ATP1B3 | P54709 | 11/20 | 0.72 |
| ▸ | FXYD2 | P54710 | 11/20 | 0.72 |
| ▸ | ATP1A4 | Q13733 | 11/20 | 0.72 |
| ▸ | GAA | P10253 | 6/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7216242 | 0.85 | ATP1A1 (0.70) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL7215986 | 0.84 | ATP1A1 (1.00) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL7218018 | 0.74 | ATP1A1 (0.78) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL7222175 | 0.74 | GAA (0.62) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL7217993 | 0.72 | ATP1A1 (1.00) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL7215726 | 0.70 | OPRD1 (0.37) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL7215736 | 0.70 | ATP1A1 (0.36) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL7216645 | 0.69 | GAA (0.82) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL24069085 | 0.64 | POLB (0.48) | GAAKMT2A | |
| SCHEMBL30209754 | 0.64 | POLB (0.48) | GAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6596739-B2 | Anticarcinogenic agents, cardiovascular disorders and antiinflammatory agents | THE PROCTER & GAMBLE COMPANY | 2003-07-22 | — | — | US | claimed |